Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice to the extraordinary general meeting of SRV Group Plc

SRV GROUP PLC     NOTICE TO THE EXTRAORDINARY GENERAL MEETING       6 MAY 2022   11.30 EEST Notice to the extraordinary general meeting of SRV Group Plc The extraordinary general meeting of SRV Group Plc is to be held on Monday 30 May 2022 at 2:00 PM (EEST) at the company’s headquarters, address: Tarvonsalmenkatu 15, 02600 Espoo. The extraordinary general meeting will be held without shareholders’ and their proxy representatives’ presence at the meeting venue on the basis of the so-called temporary act 375/2021 that entered into force on 8 May 2021. The company’s shareholders and

SRV plans a reverse split

SRV GROUP PLC     STOCK EXCHANGE RELEASE    6 May 2022      AT 11.25 EEST SRV plans a reverse split SRV Group Plc published on 28 April 2022 a programme to reorganise its balance sheet to reinforce its equity and announced that it will summon an extraordinary general meeting to be held on or about 30 May 2022 (the “EGM”), for which the board of directors will propose to issue sufficient authorisations for the execution of issuances required under the programme. The board of directors is, in addition, in connection with the programme, planning to reduce the number of the company’s

Cell Impact reports first quarter results: continued strong sales

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the first quarter.· Total revenues for the first quarter amounted to SEK 21.7 million, which is growth of 74% for the quarter. · Operating result was SEK -23.9 million (-14.4) during the quarter. · The Group's result for the quarter after financial items was SEK -24.1 million (-14.7). · Earnings per share attributable to the shareholders of the Parent Company totaled SEK -0.32 (-0.25) during the quarter. · Equity was SEK 401.5 million (187.2) or SEK 5.31 per share (3.18) on the balance sheet

BioStock: Cereno Scientific nominates two new preclinical drug candidates

Swedish biotech Cereno Scientific continues to advance on its journey toward delivering innovative treatments for patients suffering from the deadliest disease worldwide: cardiovascular disease. While lead candidate CS1 is progressing in clinical phase II within the rare disease pulmonary arterial hypertension, the company has now nominated CS585 and CS014 as the next two candidates to develop and bring into the clinic.Read the article at biostock.se: https://www.biostock.se/en/2022/05/cereno-scientific-nominates-two-new-preclinical-drug-candidates/ This is a press release from

Invitation to presentation of Quickbit’s Q3 ‘21/22 interim report

Quickbit will publish its interim report for the period 1 January – 31 March 2022 on Wednesday, 11 May 2022, at 08:00 am CET. On the same day at 11:00 am CET Quickbit will organize a conference call with web presentation for analysts and investors. Hammad Abuiseifan, CEO, and Simon Afeworki, CFO, will present and comment on the report. After the presentation there will be time for questions, both on the phone and in the web presentation. The presentation will be held in English.   The live webcast will be available at https://tv.streamfabriken.com/quickbit-interim-q3-2021-2022

DanCann Pharma's CEO: Building organization and strong results from the acquisition of CannGros ApS

COPENHAGEN, Denmark, 6 May 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that Jeppe Krog Rasmussen has decided to step down from the Board of Directors to focus on his position as the Company’s CEO.At DanCann Pharma's general meeting on Wednesday 27 April, one of the items on the agenda was “election to the Board of Directors”. And for the first time in the Company's history, Jeppe Krog Rasmussen's name was not among the candidates, as he had decided not to run. In connection with DanCann Pharma's

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release May 6, 2022 at 10:50 a.m. Nokian Tyres has received an announcement from JPMorgan Chase & Co. on May 5, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total holding and indirect holding in Nokian Tyres shares owned by the funds and accounts managed by JPMorgan Chase & Co. exceeded the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on May 3, 2022. The indirect shareholding of the funds and accounts managed by JPMorgan Chase & Co.

HPSolartech kicks off 50 MW solar park project

HPSolartech has obtained the rights to build large scale solar parks in the south of Sweden. The project includes a total of 50 MW solar panels and covers approximately 70 hectares.The project is a part of HPSolartech’s efforts to become the leading developer of solar parks in Sweden and, in time, the Nordic region. The project is built on leased land outside Emmaboda in Kalmar County and Vingåker in Södermanland County. This project is one of several projects HPSolartech is undertaking. The development portfolio includes more than 700 MW, and 90 MW is currently under construction, with

BioStock: Immunicum to present data for potential AML treatment

Acute myeloid leukaemia has one of the highest rates of recurrence after initial remission, and treatment options are limited. Immuno-oncology company Immunicum is addressing the issue by developing a cancer relapse vaccine, DCP-001. The company will present positive preclinical data at the CIMT meeting suggesting that DCP-001 works in synergy with conventional acute myeloid leukemia treatments to amplify the therapeutic effects. In parallel, the company is also on schedule to present novel clinical data on DCP-001 as a monotherapy later this quarter.Read the article at biostock.se:

Minutes of the Monetary Policy Meeting held on 27 April 2022

The Riksbank needs to conduct monetary policy to counteract the high inflation becoming entrenched in price- and wage-setting, and ensure that inflation returns to the target after a time. At its monetary policy meeting on 27 April, the Executive Board of the Riksbank therefore decided to raise the repo rate from zero to 0.25 per cent and to reduce the pace of the Riksbank’s asset purchases during the second half of this year so that the holdings decline.The global economy is still affected by the major shock caused by the pandemic and on top of this come the consequences of Russia’s

Governors approve NIB 2021 annual results and dividends

On 5 May, the annual meeting of the Board of Governors for the Nordic Investment Bank (NIB) approved the Bank’s annual accounts for 2021 and a payment of EUR 40 million as dividends to the Nordic and Baltic member countries.The disbursement of NIB’s long-term lending returned to a more normal level of EUR 2,440 million compared to EUR 4,853 million in 2020, when the Bank paid out a historically high amount in response to the Covid-19 crisis. Among the highlights of 2021, is NIB’s first sustainability-linked loan with Electrolux Professional, and a second loan — fully financed from NIB

Johannes Fabó new Chief Financial Officer at Cambio

Cambio has appointed Johannes Fabó as Chief Financial Officer. Johannes, who will join Cambio effective 15[th] of August 2022, will also be a member of the Group Leadership Team.Johannes Fabó has had multiple roles within Finance, Controlling, PMO and Strategy Development within Munters, during its time both as a Private Equity-owned company and as a listed business on the Nasdaq Stockholm Large Cap stock exchange. He has also been a Board member of XM Reality, a First North listed company, and he started his career at the Boston Consulting Group. · I am pleased to welcome Johannes

BioArctic receives new drug substance patent in the US for ABBV-0805 against Parkinson’s disease

Stockholm, May 6, 2022 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US Patent and Trademark Office (USPTO) has granted a new drug substance patent for the antibody ABBV-0805, invented by BioArctic as a potential treatment of Parkinson's disease. The patent will take effect on May 24, 2022, and expire in 2041, with the possibility of a patent term extension up until 2046.The granted substance patent (US patent no. 11,339,212) focuses on the monoclonal antibody ABBV-0805, which selectively binds to and eliminates pathological aggregated forms called oligomers and

The Board of Directors of Carbiotix AB decides on a rights issue of units

The Board of Directors of Carbiotix AB (”Carbiotix” or ”Bolaget”) has today, the 6 th of May 2022, decided to execute an issue of units (shares and attached free-of-charge warrants) with preferential right for existing shareholders, where also the general public is able to participate (”the Rights Issue”). The decision on the Rights Issue was made with support by an authorization from the Annual General Meeting held on the 22nd of April 2022 in accordance with the proposal made by the Board, communicated through a press release on the 22nd of March 2022. The Rights Issue can initially provide

SSAB highlights importance of university cooperation – EUR 100,000 to University of Oulu

SSAB Europe is contributing to the University of Oulu’s ongoing fundraising campaign with a EUR 100,000 donation for research in technical sciences at the university. SSAB and the University of Oulu have had close cooperation since the 1980s and SSAB is currently one of the university’s key partners. These days, cooperation is particularly related to steel research, the development of new demanding steel grades and to fossil-free steelmaking. Photo: Oulu university photo archive, photo: Juha Sarkkinen SSAB values the long-standing cooperation but also highlights the University

Kallelse till Årsstämma i Divio Technologies AB

Kallelse till Årsstämma i Divio Technologies AB Aktieägarna i Divio Technologies AB (publ), org. nr 559077-0730 (”Bolaget”), kallas härmed till årsstämma fredagen den 3 juni 2022, kl. 08.00 på Skeppargatan 27 i Stockholm. Rätt att delta och anmälanRätt att delta i bolagsstämman har den aktieägare som: · Dels är införd i den av Euroclear Sweden AB förda aktieboken torsdagen den 26 maj 2022 (avstämningsdagen),  · Dels har anmält sin avsikt att delta till Bolaget. Anmälan om deltagande ska ha kommit Bolaget tillhanda senast måndagen den 30 maj 2022. Anmälan om deltagande i

Esmaeilzadeh Holding expects to make a write up of its holding in Rebellion

Esmaeilzadeh Holding AB (publ) (“EHAB”) today announces that it expects to make a write up of the value of its holding in the portfolio company Rebellion Capital AB (“Rebellion”) during the second quarter of 2022. Rebellion has informed EHAB that the company intends to carry out a directed share issue of 200 MSEK at a pre-money valuation of 2.5 BSEK and that Rebellion has obtained subscription undertakings of approximately 150 MSEK. EHAB has subscribed for 80 MSEK, and has provided a guarantee for the remaining amount should the share issue not be fully subscribed. EHAB owns 40 percent

Stena Adactum AB announces outcome in the offer to the shareholders of Svedbergs i Dalstorp AB

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important information" at the end of this

Paulig awarded Food Export Company of the Year in Sweden

Paulig in Sweden exports its’ Santa Maria assortment to more than 40 markets around the world and is thereby one of Sweden’s leading food exporters. For this, the company was today awarded Food Export Company of the Year 2022. The award was presented by the Swedish Minister of Foreign Trade and Nordic Affairs, Anna Hallberg, at the Swedish Food Federation’s annual industry event.The Food Export Company of the Year award is a collaboration between the Swedish Food Federation, Business Sweden and the Swedish Ministry of Foreign Affairs. Paulig is the 22nd winner of the prize which, according

Karlatornet is now the tallest building in Gothenburg

Gothenburg has a new king of the castle. With the casting of the 45th floor of Karlatornet’s core, the building has reached a height of 146 metres. This makes Karlatornet the tallest building in the city, even though there is about 100 metres left to the top.“We have passed very many milestones in this project, the approved zoning plan, world-unique piling, casting of a record-setting base plate and halfway to the full height, to mention a few. Being the tallest in town is definitely another one that we should be pleased about. This is further proof that we have many incredibly capable

Interim report January – March 2022 for BPC Instruments

BPC Instruments (“BPC” or “the Company”) hereby publishes the interim report for the period 1 January – March 31, 2022. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report.2022-01-01 - 2022-03-31 (first quarter) · Net sales for the quarter amounted to 5 467 kSEK (5 189) · Net profit for the quarter amounted to 130 kSEK (375) · Earnings per share for the quarter amounted to SEK 0,01 (SEK 0,03*) · Cash and cash equivalents at the end of the period were 16 776 kSEK (8 803). “BPC Instruments” refers

First quarter 2022: 2022 off to a strong start

Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is proud to report growth in net sales of 116 percent combined with an adjusted EBITDA margin of 45.5 percent in the first quarter of 2022.“The beginning of 2022 was characterized by continued strong user growth. Our app was during the quarter the twentieth most downloaded app globally and about 80 percent of our montly active users use our platform daily. We are proud to help users and businesses benefit from a safer and more efficient communication experience everyday. The year began on a

There are no items matching the current filter
There are no more items matching the current filter
Back to top